Thomson Reuters Launches New Mobile Oncology Decision Support Solution for R&D Pharmaceutical Leaders
AstraZeneca speeds R&D decision making with cutting-edge life sciences technology
Facebook
Facebook
Twitter
Twitter
LinkedIn
LinkedIn
Email
Email
0 Comments
Comments
PHILADELPHIA, PA, April 24, 2012—The Intellectual Property & Science division of Thomson Reuters today announced its commitment to support R&D pharmaceutical leaders with a new oncology application for mobile tablet devices, already in use by AstraZeneca executives. The rich visualization dashboard leverages content from Thomson Reuters Cortellis, the company’s flagship life sciences platform, and provides real-time data for clinical oncology drug research and development activities.
0 Comments
View Comments
- People:
- Wendy Hamilton
- Places:
- PHILADELPHIA, PA
Press Release
Author's page
Related Content
Comments